Quris-AI’s Bio-AI Adopted By Merck For Drug Safety Evaluation
07 Jan 2025 //
GLOBENEWSWIRE
Quris-AI Acquires Nortis
29 Oct 2024 //
GLOBENEWSWIRE
Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
04 Jan 2024 //
GLOBENEWSWIRE
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
28 Sep 2023 //
GLOBENEWSWIRE
Quris-AI and MBZUAI to launch world-class Bio-AI center in Abu-Dhabi
18 Jan 2023 //
GLOBENEWSWIRE
Quris reels in $9M in funding to support innovations in trials
21 Dec 2022 //
FIERCEBIOTECH
Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
20 Dec 2022 //
GLOBENEWSWIRE
Merck KGaA taps into Quris` stem cell-powered drug screening AI
14 Feb 2022 //
FIERCEBIOTECH